August 28, 2023Open Access
View Full PaperMuvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov Identifier: NCT04472676.
Key points are not available for this paper at this time.
ClinicalTrials.gov Identifier: NCT04472676.
Nicholls et al. (Mon,) studied this question.